Found: 16
Select item for more details and to access through your institution.
ALTRUISMO DE DATOS EN EL MARCO DEL REGLAMENTO EUROPEO DE GOBERNANZA DE DATOS, ¿UN ACIERTO O MEJORABLE?
- Published in:
- Revista de Derecho Comunitario Europeo, 2024, n. 78, p. 183, doi. 10.18042/cepc/rdce.78.06
- By:
- Publication type:
- Article
Synergistic Highly Potent Targeted Drug Combinations in Different Pheochromocytoma Models Including Human Tumor Cultures.
- Published in:
- Endocrinology, 2019, v. 160, n. 11, p. 2600, doi. 10.1210/en.2019-00410
- By:
- Publication type:
- Article
Optimization of Primary Human Bronchial Epithelial 3D Cell Culture with Donor-Matched Fibroblasts and Comparison of Two Different Culture Media.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 4, p. 4113, doi. 10.3390/ijms24044113
- By:
- Publication type:
- Article
Heat Shock Protein 90 as a Prognostic Marker and Therapeutic Target for Adrenocortical Carcinoma.
- Published in:
- Frontiers in Endocrinology, 2019, p. 1, doi. 10.3389/fendo.2019.00487
- By:
- Publication type:
- Article
Responses to systemic therapy in metastatic pheochromocytoma/paraganglioma: a retrospective multicenter cohort study.
- Published in:
- European Journal of Endocrinology, 2023, v. 189, n. 5, p. 546, doi. 10.1093/ejendo/lvad146
- By:
- Publication type:
- Article
Combination of 5-Fluorouracil With Epigenetic Modifiers InducesRadiosensitization, Somatostatin Receptor 2 Expression and Radioligand Binding in Neuroendocrine Tumor Cells in Vitro.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.224048
- By:
- Publication type:
- Article
Combination of 5-Fluorouracil with Epigenetic Modifiers Induces Radiosensitization, Somatostatin Receptor 2 Expression, and Radioligand Binding in Neuroendocrine Tumor Cells In Vitro.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 9, p. 1240, doi. 10.2967/jnumed.118.224048
- By:
- Publication type:
- Article
Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic Responses.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 10, p. 2676, doi. 10.1210/clinem/dgad166
- By:
- Publication type:
- Article
The MTH1 inhibitor TH588 demonstrates anti-tumoral effects alone and in combination with everolimus, 5-FU and gamma-irradiation in neuroendocrine tumor cells.
- Published in:
- PLoS ONE, 2017, v. 12, n. 5, p. 1, doi. 10.1371/journal.pone.0178375
- By:
- Publication type:
- Article
Antitumoral Activity of the MEK Inhibitor Trametinib (TMT212) Alone and in Combination with the CDK4/6 Inhibitor Ribociclib (LEE011) in Neuroendocrine Tumor Cells In Vitro.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1485, doi. 10.3390/cancers13061485
- By:
- Publication type:
- Article
Inhibition of Wnt/β-Catenin Signaling in Neuroendocrine Tumors In Vitro: Antitumoral Effects.
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 345, doi. 10.3390/cancers12020345
- By:
- Publication type:
- Article
GSK3α/β: A Novel Therapeutic Target for Neuroendocrine Tumors.
- Published in:
- Neuroendocrinology, 2018, v. 106, n. 4, p. 335, doi. 10.1159/000481887
- By:
- Publication type:
- Article
The Novel Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) Alone and in Dual-Targeting Approaches Demonstrates Antitumoral Efficacy in Neuroendocrine Tumors in vitro.
- Published in:
- Neuroendocrinology, 2017, v. 106, n. 1, p. 58, doi. 10.1159/000463386
- By:
- Publication type:
- Article
The HDM2 (MDM2) Inhibitor NVP-CGM097 Inhibits Tumor Cell Proliferation and Shows Additive Effects with 5-Fluorouracil on the p53-p21-Rb-E2F1 Cascade in the p53<sup>wild type</sup> Neuroendocrine Tumor Cell Line GOT1.
- Published in:
- Neuroendocrinology, 2017, v. 106, n. 1, p. 1, doi. 10.1159/000453369
- By:
- Publication type:
- Article
Cabozantinib and Tivantinib, but Not INC280, Induce Antiproliferative and Antimigratory Effects in Human Neuroendocrine Tumor Cells in vitro: Evidence for 'Off-Target' Effects Not Mediated by c-Met Inhibition.
- Published in:
- Neuroendocrinology, 2016, v. 103, n. 3/4, p. 383, doi. 10.1159/000439431
- By:
- Publication type:
- Article
Additive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling Pathways.
- Published in:
- PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0143830
- By:
- Publication type:
- Article